Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACA | Q13085 | 4/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MPI | P34949 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352882 | 1.00 | ACACA (0.50) | ACACAEGFRMAOAMAOBKDM4E | |
| SCHEMBL17508350 | 0.96 | ACACA (0.51) | ACACAEGFRMAOAMAOBKDM4E | |
| SCHEMBL10629041 | 0.91 | LTB4R (0.50) | ACACAMAOAMAOBKDM4EMAPK1 | |
| SCHEMBL17508372 | 0.89 | MAOA (0.42) | ACACAEGFRMAOAMAOBKDM4E | |
| SCHEMBL10630879 | 0.88 | GRM2 (0.58) | ACACAMAOAMAOBKDM4EALDH1A1 | |
| SCHEMBL10627563 | 0.88 | ALDH1A1 (0.55) | ACACAKDM4EHTTALDH1A1HPGD | |
| SCHEMBL17508354 | 0.84 | GSTP1 (0.46) | ACACAMAOAMAOBKDM4EUSP2 | |
| SCHEMBL10627554 | 0.84 | LTB4R (0.51) | ACACA | |
| SCHEMBL22650970 | 0.83 | ESR1 (0.50) | ACACAKDM4EMAPK1ALDH1A1HPGD | |
| SCHEMBL11826284 | 0.83 | MAPK1 (0.65) | ACACAKDM4EMAPK1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105198806-A | Method for synthesizing quinoline by aromatic amine and diketone | UNIV NANYANG NORMAL | 2015-12-30 | — | — | CN | claimed |
| CN-103467447-B | One class electroluminescent organic material and applying in the devices | Jilin Optical and Electronic Materials Co., Ltd. (CN) | 2015-10-28 | — | — | CN | claimed |
| CN-103467447-A | Novel organic electroluminescent (EL) material and application thereof in devices | JILIN OPTICAL & ELECTRONIC MATERIALS CO LTD | 2013-12-25 | — | — | CN | claimed |
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11527723-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2022-12-13 | — | — | US | disclosed |
| WO-2022239930-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | 엘티소재주식회사 | 2022-11-17 | — | — | WO | disclosed |
| US-11387418-B2 | Organic light emitting element and composition for organic material layer in organic light emitting element | LT MATERIALS CO., LTD. (KR) | 2022-07-12 | — | — | US | disclosed |
| EP-3604298-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LT MATERIALS CO LTD (KR) | 2022-03-30 | — | — | EP | disclosed |
| US-11208401-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-12-28 | — | — | US | disclosed |
| US-11201296-B2 | Compounds having fluorene structures | MERCK PATENT GMBH (DE) | 2021-12-14 | — | — | US | disclosed |
| EP-0210084-B1 | AMIDES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | RHONE-POULENC SANTE (FR) | 1989-02-08 | — | — | EP | disclosed |
| US-4788204-A | TRANQUILIZERS; ANTICONVULSANTS; ANGINA AND IMMUNODIFICIENCY TREATMENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4788199-A | ANXIOLYTICS, ANTICONVULSANTS, ANTIANGINA AGENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4677107-A | 2-PIPERAZINYL-4-PHENYLQUINOLINES | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1987-06-30 | — | — | US | disclosed |
| EP-0210084-A1 | Amides, processes for their preparation and medicaments containing them | RHONE-POULENC SANTE (FR) | 1987-01-28 | — | — | EP | disclosed |
| EP-0127189-A2 | Anti-peptic ulcer agent | Dainippon Pharmaceutical Co., Ltd. (JP) | 1984-12-05 | — | — | EP | disclosed |
| US-4237135-A | ANTIDEPRESSANTS | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1980-12-02 | — | — | US | disclosed |
| US-4000151-A | TRANQUILIZERS, SEDATIVES | THE UPJOHN COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-4000153-A | TRANQUILIZERS, SEDATIVES | THE UPJOHN COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11387418-B2 | Organic light emitting element and composition for organic material layer in organic light emitting element | CRY1, CYBA, L1CAM | ACACA 3523/4885EGFR 3820/4885MAOA 121/4885 |
| US-11208401-B2 | Materials for organic electroluminescent devices | DDT, CELF2, BRD3 | ACACA 3634/4885EGFR 2517/4885MAOA 1116/4885 |
| US-11201296-B2 | Compounds having fluorene structures | FSCN1, EFNA1, FLNA | ACACA 3682/4885EGFR 1741/4885MAOA 695/4885 |
| US-11527723-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | ACACA 2714/4885EGFR 2783/4885MAOA 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.